These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

724 related articles for article (PubMed ID: 25601619)

  • 21. Cancer stem cells: a challenging paradigm for designing targeted drug therapies.
    Khan IN; Al-Karim S; Bora RS; Chaudhary AG; Saini KS
    Drug Discov Today; 2015 Oct; 20(10):1205-16. PubMed ID: 26143148
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nanomedicine strategies for sustained, controlled and targeted treatment of cancer stem cells.
    Gao J; Li W; Guo Y; Feng SS
    Nanomedicine (Lond); 2016 Dec; 11(24):3261-3282. PubMed ID: 27854161
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Delivering cancer stem cell therapies - a role for nanomedicines?
    Schätzlein AG
    Eur J Cancer; 2006 Jun; 42(9):1309-15. PubMed ID: 16682183
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting autophagy in cancer stem cells as an anticancer therapy.
    Lei Y; Zhang D; Yu J; Dong H; Zhang J; Yang S
    Cancer Lett; 2017 May; 393():33-39. PubMed ID: 28216370
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Progress in the study of targeted drug delivery systems for cancer stem cells].
    Qiao MX; Zhang XJ; Shuang BA; Hu HY; Zhao XL; Chen DW
    Yao Xue Xue Bao; 2013 Apr; 48(4):477-83. PubMed ID: 23833932
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Implications and Future Perspectives of Nanomedicine for Cancer Stem Cell Targeted Therapies.
    Singh VK; Saini A; Chandra R
    Front Mol Biosci; 2017; 4():52. PubMed ID: 28785557
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recent trends in cancer drug resistance reversal strategies using nanoparticles.
    Palakurthi S; Yellepeddi VK; Vangara KK
    Expert Opin Drug Deliv; 2012 Mar; 9(3):287-301. PubMed ID: 22339554
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Cancer Stem Cells (CSCs) as a Rational Therapeutic Cancer Target, and Screening for CSC-targeting Drugs].
    Mashima T
    Yakugaku Zasshi; 2017; 137(2):129-132. PubMed ID: 28154319
    [TBL] [Abstract][Full Text] [Related]  

  • 29. EpCAM-Antibody-Labeled Noncytotoxic Polymer Vesicles for Cancer Stem Cells-Targeted Delivery of Anticancer Drug and siRNA.
    Chen J; Liu Q; Xiao J; Du J
    Biomacromolecules; 2015 Jun; 16(6):1695-705. PubMed ID: 25988863
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cancer stem cells and strategies for targeted drug delivery.
    Cao J; Bhatnagar S; Wang J; Qi X; Prabha S; Panyam J
    Drug Deliv Transl Res; 2021 Oct; 11(5):1779-1805. PubMed ID: 33095384
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cancer stem cell (CSC) inhibitors: a review of recent patents (2012-2015).
    Kharkar PS
    Expert Opin Ther Pat; 2017 Jul; 27(7):753-761. PubMed ID: 28460551
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Photochemical internalisation, a minimally invasive strategy for light-controlled endosomal escape of cancer stem cell-targeting therapeutics.
    Selbo PK; Bostad M; Olsen CE; Edwards VT; Høgset A; Weyergang A; Berg K
    Photochem Photobiol Sci; 2015 Aug; 14(8):1433-50. PubMed ID: 25805311
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Natural Compounds Targeting Cancer Stem Cells: A Promising Resource for Chemotherapy.
    Das PK; Zahan T; Abdur Rakib M; Khanam JA; Pillai S; Islam F
    Anticancer Agents Med Chem; 2019; 19(15):1796-1808. PubMed ID: 31272363
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cancer stem cells (CSCs), cervical CSCs and targeted therapies.
    Huang R; Rofstad EK
    Oncotarget; 2017 May; 8(21):35351-35367. PubMed ID: 27343550
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cancer stem cell heterogeneity: origin and new perspectives on CSC targeting.
    Eun K; Ham SW; Kim H
    BMB Rep; 2017 Mar; 50(3):117-125. PubMed ID: 27998397
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Understanding and targeting cancer stem cells: therapeutic implications and challenges.
    Chen K; Huang YH; Chen JL
    Acta Pharmacol Sin; 2013 Jun; 34(6):732-40. PubMed ID: 23685952
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeting Cancer Stem Cells in Castration-Resistant Prostate Cancer.
    Yun EJ; Zhou J; Lin CJ; Hernandez E; Fazli L; Gleave M; Hsieh JT
    Clin Cancer Res; 2016 Feb; 22(3):670-9. PubMed ID: 26490309
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selective killing of cancer stem cells by a novel dual-targeting strategy.
    Lou D; Wang B; Wang Y; Cao Y
    Med Hypotheses; 2012 Oct; 79(4):430-2. PubMed ID: 22818853
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cervical cancer stem cells: opportunities and challenges.
    Chhabra R
    J Cancer Res Clin Oncol; 2015 Nov; 141(11):1889-97. PubMed ID: 25563493
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.